1. Home
  2. IDYA vs SEB Comparison

IDYA vs SEB Comparison

Compare IDYA & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.85

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Seaboard Corporation

SEB

Seaboard Corporation

SELL

Current Price

$3,955.01

Market Cap

3.8B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
IDYA
SEB
Founded
2015
1918
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.8B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
IDYA
SEB
Price
$32.85
$3,955.01
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
★ $52.29
N/A
AVG Volume (30 Days)
★ 840.4K
7.3K
Earning Date
11-03-2026
10-27-2026
Dividend Yield
N/A
★ 0.23%
EPS Growth
61.90
★ 467.71
EPS
N/A
★ 283.99
Revenue
$218,710,000.00
★ $5,809,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$189.87
N/A
P/E Ratio
★ N/A
$14.02
Revenue Growth
★ 3024.43
7.99
52 Week Low
$26.81
$3,140.01
52 Week High
$42.68
$5,989.37

Technical Indicators

Market Signals
Indicator
IDYA
SEB
Relative Strength Index (RSI) 27.61 40.35
Support Level $29.74 $3,864.03
Resistance Level $35.14 $4,143.09
Average True Range (ATR) 1.29 110.70
MACD -0.43 1.43
Stochastic Oscillator 5.25 19.09

Price Performance

Historical Comparison
IDYA
SEB

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

Share on Social Networks: